Biotech: Time For A Pause To Start 2026
Source: SeekingAlpha
2026-01-02 06:52:42 ET
The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the administration in April. This ETF is up around 20% from my last article on it early in October, when I was still bullish on the sector....
Read the full article on Seeking Alpha
For further details see:
Biotech: Time For A Pause To Start 2026
Praxis Precision Medicines Inc.
NASDAQ: PRAX
PRAX Trading
-2.42% G/L:
$311.535 Last:
26,627 Volume:
$306.48 Open:
PRAX Latest News
March 09, 2026 09:54:00 am
Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment
March 04, 2026 04:01:00 pm
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2026 01:49:01 pm
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year
February 22, 2026 02:36:11 pm
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million
PRAX Stock Data
$8,057,264,446
20,105,683
0.7%
83
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
